INNOVATION PHARMACEUTICALS INC. (IPIX)
Clinical trial NCT07478211 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-07-31 → 2026-09-30 3. primary completion date: 2026-07-31 → 2026-09-30 4. enrollment type: ESTIMATED → ACTUAL 5. collaborators added: Fresenius Kabi (Schweiz) AG, DexCom, Inc., Bern Medtech Collaboration Call
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical